New research out of Kansas State University (KState) College of Veterinary Medicine suggests a bioactive composition designed to build lean muscle could benefit dogs that have undergone a common orthopedic surgery. Published in PLOS ONE, the findings, titled, “Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy,” summarize the results of a 100-dog study, which explores the potential benefits of Myos Rens Technology’s proprietary product on canines following tibial-plateau leveling osteotomy (TPLO). According to the study, when compared to those that received a placebo, dogs who were administered the tested product: experienced reduced muscle loss; did not experience increased myostatin levels; and experienced greater improvement in weight bearing capacity on their operated limb. To read the study, click here.
